Review: Anti-infectives Recent developments in the antiviral therapy of influenza

References

• WISELKA M: Influenza: diagnosis, management and pro-phylaxis. BMJ(1994) 308(6940): 1341–1352.
   PubMedGoogle Scholar
• HAYDEN FG: Combinations of antiviral agents for treat-ment of influenza virus infection. J. Antimicrob. Chemother. (1986) 18(Suppl. B): 177–183.
   Google Scholar
• BELSHE RB, BURK B, NEWMAN F, CERRUTI RI, SIM IS: Resistance of influenza A virus to amantadine and rintantadine: results of one decade of surveillance. J. Infect. (1989) 159: 430–435.
   Google Scholar
• HAYDEN FG, BELSHE RB, GLOVER RD, HAY AJ, OAKES MG, SOO W: Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. New Engll Med. (1989) 321: 1697–1702.
   Google Scholar
• SIDWELL RW, BAILEY KW, WONG MH, MORRISON AG, HUFFMAN JH: Rapid in vivo development of influenza resistance to amantadine and rimantadine. Antiviral Res. (1995) 26(3): A348.
   Google Scholar
• SWEET C. HAYDEN FG, JAKEMAN KJ, GRAMBAS S, IIAY AJ: Virulence of rinaantadine-resistant human influenza A (H3N2) viruses in ferrets. J. Infect. Dis. (1991) 164: 969–972.
   PubMedGoogle Scholar
• KUBAR OL, BRJANTSEVA EA, NHUTINA LE, ZLIDIKOV DM: The importance of virus drug-resistance in the treat-ment of influenza A with rimantadine. Antiviral Res. (1989) 11 313–316.
   PubMedGoogle Scholar
• BELSHE RB, HAY AI: Drug resistance and mechanismsof action on influenza A viruses. J. Respir. Dis. (1989) 10: 552–556
   Google Scholar
• HAYDEN FG, HOFFMAN HE, SPYKER DA: Differences inside effects of amantidine and rimantidine relate to differences in pharmacokinetics. Antimicrob. Agents Chemother (1983) 23: 458–464.
   PubMed Web of Science ®Google Scholar
• BETTS R- Potential agents in the treatment of influenza. Curr. Opin. Infect. Dis. (1992) 5: 811–815.
   Web of Science ®Google Scholar
• HIRSCH MS, KAPLAN JC: Antiviral agents. In: Fields Viral-ogy (1990) Field B, Knipe DM (Eds.), Raven Press, New York, Chapter 18: 455.
   Google Scholar
• SMMI CB, CHARETTE RP, FOX JP, COONEY MK, HALL CE:Lack of effect of oral ribavirin in naturally occuring influenza A virus (H1N1) infection. J. Infect. Dis. (1980) 141: 548–554.
   PubMedGoogle Scholar
• GILBERT BE, WILSON SZ, KNIGHT V, COCCI I RB, QUARLES JM, DURE L, HAYES N, WILLIS C: Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1 Ni) and B/Texas 1/84. Antimicrob. Agents Chemother. (1985) 27: 309–313.
   PubMed Web of Science ®Google Scholar
• CARRAT F, VALLERON A-J: Le vaccin antigrippal: Revue bibliographique. Rev. Mal. Resp. (1994) 11: 239–255.
   PubMedGoogle Scholar
• MADREN LK, SHIPMAN C, Jr., HAYDEN FG: In vitro inhibi-tory effects of combinations of anti-influenza agents. Antiviral Chem. Chemother. (1995) 6(2): 109–113.
   Google Scholar
• HAYDEN FG, ROLLINS B, MADREN LK: Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithilium. Antiviral Res. (1994) 25: 123–131.
   PubMed Web of Science ®Google Scholar
• RYAN DM, TICEIIURST J. DEMPSEY MH: The anti-influ-enza virus activity of a novel neuraminidase (sialirlase) inhibitor 4-guanidino-Neu5Ac2en. Antiviral Res. (1994) 23\(Suppl. 1): 77.
   Google Scholar
• WOODS JM, BETHELL RC, COATES JAV, HEALY N, HISCOXS, PEARSON BA, RYAN DM, TICEHURST J, TILLING J, WALCOTT SM, PENN CR: 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective Inhibitor both of the sialiehse (neuratniniriase) and of growth of a wide range of influenza A and B viruses in vitro. Antimicrob. Agents Chemother. (1993) 37(7): 1473–1479.
   PubMedGoogle Scholar
• HAYDEN FG, TREANOR JJ, ESINHART J, EASON CU, HUSSEY EK: Twice daily intranasal GG167 for experi-mental influenza A. Antiviral Res. (1995) 26(3): A300.
   Google Scholar
• HAYDEN F, LOBO M, ESINHART J, HUSSEY E: Efficacy of4-guaniclino-Neu5Ac2en in experimental human influ-enza A virus infection. Abstracts of the 34th ICAAC (1994) Session 96: 190.
   Google Scholar
• VON ITZSTEIN M, BARRY JG, CHONG AKJ: Anti-infectives overview: the development of potential anti-influenza drugs. Cum Opin. Thera. Patents (1993) 3(12): 1755–1762.
   Google Scholar
• PALESE P, GARCIA-SASTRE A: Encyclopedia of Virology Webster RG, Granoff A (Eds.), Academic Press, (1994): 715–722
   Google Scholar
• STEINEKE-GROBER A, VEY M, ANGLLKER H, SHAW E, THOMAS G, ROBERTS C, KLENK HD, GARTEN W: Influ-enza virus hemagglutinin with multthasic cleavage site Is activated by furin, a subtilisin-like endoprotease. EMBO J. (1992) 11: 2407–2414.
   PubMedGoogle Scholar
• LAZAROWITZ SG, CHOPPIN PW: Enhancement of theInfectivity of influenza A and B viruses by proteolytic cleavage of the haemagglutinin polypeptide. Virology (1975) 68. 440–454.
   PubMed Web of Science ®Google Scholar
• LANZREIN M, SCHEGEL A, KEMPF C: Entry and ttncoating of enveloped viruses. Biochem J. (1994) 302: 313–320.
   PubMedGoogle Scholar
• BuLLOHCH PA, HHCHSON MH, SKEHEL JJ, WILEY DC: Structure of influenza haemagglutinin at the pH of membrane fusion. Nature (1994) 371: 37–43
   PubMedGoogle Scholar
• CARR CM, KIM PS: A spring loaded mechanism for theconformational change of influenza hemagglutinin. Cell (1993) 73: 823–832.
   PubMed Web of Science ®Google Scholar
• NAYAK DP, JABBAR MA: Structural domains and organ-izational conformation involved in the sorting and transport of influenza virus transmembrane proteins. Ann. Rev. Microbiol. (1989) 43: 465–501.
   PubMedGoogle Scholar
• WATOWICH SJ, SKEHEL JJ, WILEY DC: Crystal structure of influenza virus hemagglutinin in complex with high-affinity receptor analogs. Structure (1994) 2(8): 719–731.
   PubMedGoogle Scholar
• WEINHOLD EG, KNOWLES JR: Design and evaluation of a tightly binding fluorescent ligand for influenza A hemagglutinin. J. Am. Chem. Soc. (1992) 114: 9270–9275
   Google Scholar
• TOOGOOD PL, GALLLKER PK, GLICK GD, KNOWLES _JR: Monovalent sialosides that bind tightly to influenza A virus. J. Med. Chem. (1991) 34: 3138–3140.
   PubMed Web of Science ®Google Scholar
• SEBESAN S, DUUS JO, DOMAILLE P, KELM S. PAULSON JC: Synthesis of cluster sialoside inhibitors for influenza virus. J. Am. Chenz. Soc. (1991) 113: 5865–5866.
   Google Scholar
• GLICK GD, TOOGOOD PL, WILEY DC, SKEHEL JJ, KNOWLES JR: Ligand recognition by influenza virus. The binding of bivalent sialosides. J. Biol. Chem. (1991) 266: 23660–23669.
   PubMedGoogle Scholar
• GLICK GD, KNOWLES JR: Molecular recognition of biva-lent sialosides by influenza virus. J. Am. Chem. Soc.(1991) 113: 4701–4703.
   Web of Science ®Google Scholar
• SPALTENSTEIN A, WHITESIDES GM: Polyacrylamides bearing pendant a-siabtside groups strongly inhibit agglutination of erythrocytes by influenza virus. J. Am. Chem. Soc. (1991) 113: 686–687.
   Web of Science ®Google Scholar
• MOCHALOVA LV, TUZIKOV AB, MARININA VP, GAM-BARYAN AS, BYRAMOVA NE, BOVIN NV, MATROSOVICH MN: Synthetic polymeric inhibitors of influenza virus receptor-binding activity suppress virus replication. Antiviral Res. (1994) 23(3-4): 179–190.
   PubMedGoogle Scholar
• SPEVAK W, NAGY JO, CHARYCH DH, SHAEFER ME, GIL-BERT JH BEDNARSKI MD: Polymerized liposomes con-taining C-glycosides of sialic add: potent inhibitors of influenza virus in vitro infectivity. J. Am. Chem. Soc. (1993) 113: 1146–1147.
   Google Scholar
• KRUMBEIGEL M, DIMITROV DS, PURI A, BLUMENTHAL R:Dextran sulfate inhibits fusion of influenza virus and cells expressing influenza hemaggiutlnin with red blood cells. Biochim. Biophys. Ada (1992) 1110(2): 158–164.
   PubMedGoogle Scholar
• IKEDA S, NEYTS J, VERMA S, WICKRAMASINGHE A, MO-HAN P, DE CLERCQ E: In vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulphonic add pointers interacting with virus-oell bind-ing and/or fusion. Antimicrob. Agents Chemother. (1994) 38(2): 256–259.
   PubMedGoogle Scholar
• BODIAN DL, YAMASAKI RB, BUSWELL RI, STERNAS FS, WHITE JM, KUNTZ ID: Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones. Biochemistiy(1993) 32: 2967–2978.
   PubMed Web of Science ®Google Scholar
• BETHELL RC, GRAY NM, PENN CR: The kinetics of the acid-induced conformational change of influenza virus haemagglutinin can be followed using 1,1'-bis(4-anil-ino-5-naphthalene sulphonic add). Biochem. Biophys. Res. Comm. (1995) 206(1): 355–361.
   PubMedGoogle Scholar
• GOLYANDO PB, OVCHARENKO AV, ZHIRNOV OP: Aprot-inin treatment of influenza B virus bronchopneumonia of mice. Antiviral Res. (1994) 23\(Suppl. 1): 139.
   Google Scholar
• SOMEYA A, TANAKA N, OKUYUMA A: Inhibition of influ-enza virus A/WSN replication by serine protease inhibi-tors and anti-protease antibodies. Antivir. Chem. Chemother. (1994) 5(3): 187–190.
   Google Scholar
• HAY AJ: The action of adamantanarnines against influ-enza A viruses: inhibition of the M2 ion channel pro-tein. Virology (1992) 3: 21–30.
   Google Scholar
• KRUG RM, ALONSO-CAPLAN TV, JULKUNEN I, KATZE MG: Expression and replication of the influenza virus genome. In: The Influenza Viruses (1989), Krug RM (Ed.) Plenum Press, New York, pp 89–152.
   Google Scholar
• HENSENS OD, GOETZ MA, L1ESCH JM, ZINK DL, RAGH00-BAR SL, I IELMS GL, SINGH SB: Isolation and structure of flutirnide, a novel endonuclease inhibitor of influenza virus. Tel. Lett. (1995) 36(12): 2005–2008.
   Google Scholar
• SINGH SB Total synthesis of flutimide, a novel endonu-clease inhibitor of influenza virus. Tet. Lett. (1995) 36(12): 2009–2012.
   Google Scholar
• TOMASSINI J, SELNICK H, DAVIES ME, ARMSTRONG ME,BALDWIN J, BOURGEOIS M, HASTINGS J, HAZUDA D, LEWIS J, MCCLEMENTS W, PONTICELLO G, RADZILOWSKI E, SMITII G, TEBBEN A, WOLFE A: Inhibition of cap (m7GpppiEm)-dependent endonudease of influenza vi-rus by 4-substituted 2,4-dioxobutanoic acid corn-pounds. Antimicrob. Agents Chemother. (1994) 38(12): 2827–2837.
   PubMed Web of Science ®Google Scholar
• COLACINO MJ, TANG JC: The search for anti-influenza compounds with spedfic reference to LY217896 and its sodium salt. Drugs Future (1982) 17(11): 1019–1028.
   Google Scholar
• BIRCH GM, CALACINO JM, EHLHARDT WJ, BALZARINI J: The intracellular formation of a mononucleotide of the anti-influenza agent 1,3,4-thiadiazole-2-yi cyanamide (LY217896). Antiviral Chem. Chemother. (1995) 6(3): 127–137.
   Google Scholar
• HAYDEN FG, TUNKEL AR, TREANOR JJ, BETTS RF, ALLER-HEILIGEN S, HARRIS J: Oral LY217896 for prevention of experimental influenza A virus infection and illness in humans. Antimicrob. Agents Chemother. (1994) 38(5). 1178–1181.
   PubMedGoogle Scholar
• TISDALE M, APPLEYARD G, TUTTLE JV, NELSON DJ, NUS-INOFF-LEHRMAN S, AL NAKIB W, STABLES JN, PURIFOY DJM, POWELL KL, DARBY G: Inhibition of influenza A and B viruses by 2'-deoxy-2'-fluroribosides. Antiviral Chem. Chemother. (1993) 4(5): 281–287.
   Google Scholar
• TISDALE M, LOWE D, STABLES J, JAKEMAN KJ, SWEET C:Single dose efficacy of 2'-fluorodGuo in the mouse and ferret influenza models. Antiviral Res.(1994) 23\(Suppl. 1): 142.
   Google Scholar
• TUTTLE JV, TISDALE M, KRENITSKY TA: Purine 2'-deoxy-2' fluororibosides as anti-influenza virus agents. J. Med. Chem. (1993) 36: 119–125.
   PubMed Web of Science ®Google Scholar
• VARGHESE JN, LAVER WG, COLMAN PM: Structure of theinfluenza virus glycoprotein antigen neuraminidase at 2.9A resolution. Nature (1983) 303: 35–40.
   PubMed Web of Science ®Google Scholar
• COLMAN PM, VARGHESE JN, LAVER WG: Structure of thecatalytic and antigenic sites in influenza virus. Nature (1983) 303: 41–44.
   PubMed Web of Science ®Google Scholar
• VARGHESE JN, MCKIMM-BRESCHKIN JL, CALDWELL JB, KORTT A, COLMAN PM: The structure of the complex between influenza virus neuraminidase and sialic add, the viral receptor. Proteins (1992) 14: 327–332.
   PubMed Web of Science ®Google Scholar
• BOSSART-WHITAKER P, CARSON M, BABU YS, SMITH CD, LAVER WG, AIR GMJ: Three dimensional structure of Influenza A N9 neuraminidase and its complex with the inhibitor 2-deotry 2,3-dehydro-N-acetyl neuraminic acid. J. Mol. Biol. (1993) 232: 1069–1083.
   PubMed Web of Science ®Google Scholar
• BURMEISTER WP, RUIGROK Rwii, CUSACK S: The 2.2A resolution crystal structure of influenza B neuramini-dase complex with sialic acid. EMBOJ (1992) 11: 49–56.
   Google Scholar
• JANAKIRARNAN MN, WHITE CL, LAVER WG, AIR GM, LUO M: Structure of influenza virus neuraminidase B/Lee/40 complexed with sialic acid and a dehyciro analog at 1.8 A resolution: implications for the catalytic mechanism. Biochemistry (1994) 33: 8172–8179.
   Google Scholar
• CHONG KJ, PEGG MS, TAYLOR NR, VON ITZSTEIN M: Evidence for a sialosyl cation transition state complex in the reaction of sialidase from influenza. Fur. J. Bio-chem. (1992) 207: 335–343.
   Google Scholar
• Guo x, LAVER WG, VIMR E, SINNOTT ML: Catalysis by Two sialidases with the same fold but different stereo-chemical courses: a mechanistic comparison of the enzymes from influenza A virus and Salmonella ty-phimurium. J. Am. Chem, Soc. (1994) 116: 5572–5578.
   Google Scholar
• HART GJ, BETHELL RC: 2,3-Didehydro-2,4-dideotry-4-guanidino-N-acetyl-D-neuraminic acid (4-guanidino-Neu5Ac2en) is a slow-binding inhibitor of sialidase from both influenza A and influenza B virus. Biochem-istry and Molecular Biology International (1995): in press.
   Google Scholar
• VON ITZSTEIN M, WU W-Y, KOK GB, PEGG MS, DYASON JC, JIN B, PHAN TV, SMYTHE ML, WHITE HF, OLIVER SW, COLMAN PM, VARGHESE JN, RYAN DM, WOODS JM, BETHELL RC, HOTHAM VJ, CAMERON JM, PENN CR: Ra-tional design of potent sialidase-based inhibitors of influenza virus replication. Nature (1993) 363: 418–423.
   PubMed Web of Science ®Google Scholar
• JEDRZEJAS MJ, SINGH S, BROUILLETTE WJ, LAVER WG, AIR GM, LUO M: Structures of aromatic inhibitors of influ-enza virus neuranainidase. Biocbernistly (1995) 34: 3144–3151.
   PubMed Web of Science ®Google Scholar
• JEDRZEJAS MJ, SINGH S, BROUILLETTE WJ, LAVER WG, AIRGM, LUO M: Poster at the Winter Conferenece on Bioorganic and Medicinal Chemistry, Steamboat Springs, Colorado, (1995).
   Google Scholar
• SMEE DF et al.: 4,6-Dibenzamidopyrazolo[3,4-d]pyrimid-Me is a highly selective inhibitor of cytomegalovirus adsorption to cells. Antiviral Res. (1990) 13(1): 1–10.
   PubMedGoogle Scholar
• NARUSE N, TENMYO 0., KOBARU S, HATORI M: New antiviral antibiotics, Kistnmicin A and B 1. Taxonomy, production, isolation, physicochemical properties and biological activities. J. Antibiotics (1993) 46: 1804–1811.
   Google Scholar
• NARUSE N, OKA M, KONISHI M, OKI T: New antiviral antibiotics, Kistamicins A and B. 11. Structure determi-nations. J. Antibiotics (1993) 46: 18124818.
   Google Scholar
• VIDEBAK LM, AALKJAR C, MULVANY MJ: Pinacidil opens K+-selective channels causing hyperpolarization and relaxation. Br. J. Pbarmacol. (1988) 95(1): 103–108.
   PubMedGoogle Scholar
• OTT S, WUNDERLI-ALLENSPACH H. Effect of the virostaticNorakin (triperi•den) on influenza virus activities. An-tiviral Res (1994) 24(1). 37–42
   PubMedGoogle Scholar